Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | CFD | P00746 | 2/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.39 |
| ▸ | TNFSF11 | O14788 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.35 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.35 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | GGT1 | P19440 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10061893 | 0.85 | ALDH1A1 (0.40) | TSHRALDH1A1KDM4EGAARAB9A | |
| SCHEMBL10351088 | 0.81 | KDM4E (0.51) | TSHRALDH1A1KDM4EGAARAB9A | |
| SCHEMBL10438024 | 0.81 | ALDH1A1 (0.46) | TSHRALDH1A1KDM4EGAARAB9A | |
| SCHEMBL6247630 | 0.78 | TSHR (0.58) | TSHRALDH1A1KDM4EGAARAB9A | |
| SCHEMBL987450 | 0.77 | ALDH1A1 (0.47) | TSHRALDH1A1KDM4EGAARAB9A | |
| SCHEMBL11327929 | 0.76 | CFD (0.44) | TSHRALDH1A1KDM4EGAARAB9A | |
| SCHEMBL11319980 | 0.76 | CFD (0.44) | TSHRALDH1A1KDM4EGAARAB9A | |
| SCHEMBL4520980 | 0.75 | ACHE (0.46) | TSHRALDH1A1KDM4EGAARAB9A | |
| SCHEMBL17072170 | 0.75 | GAA (0.49) | TSHRALDH1A1KDM4EGAARAB9A | |
| SCHEMBL10079209 | 0.75 | RECQL (0.51) | KDM4EGAARAB9APTGS2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10034851-B2 | Metal-salen complex compound, local anesthetic and antineoplastic drug | IHI CORPORATION (JP) | 2018-07-31 | — | — | US | disclosed |
| US-10034941-B2 | Iron-salen complex | IHI CORPORATION (JP) | 2018-07-31 | — | — | US | disclosed |
| US-10030039-B2 | Anti-cancer agent and cancer cell killing method | IHI CORPORATION (JP) | 2018-07-24 | — | — | US | disclosed |
| EP-2557155-B1 | METAL SALEN COMPLEX DERIVATIVE AND PROCESS FOR PRODUCTION THEREOF | IHI CORP (JP) | 2018-06-13 | — | — | EP | disclosed |
| US-9779862-B2 | Magnetic substance and magnetic substance manufacturing method | IHI CORPORATION (JP) | 2017-10-03 | — | — | US | disclosed |
| US-20170240581-A1 | ANTI-CANCER AGENT AND CANCER CELL KILLING METHOD | ISHIKAWA, YOSHIHIRO (JP) | 2017-08-24 | — | — | US | disclosed |
| US-9603940-B2 | Metal salen complex derivative and process for production thereof | IHI CORPORATION (JP) | 2017-03-28 | — | — | US | disclosed |
| US-9505732-B2 | Auto magnetic metal salen complex compound | IHI CORPORATION (JP) | 2016-11-29 | — | — | US | disclosed |
| US-9469668-B2 | Magnetic substance | IHI CORPORATION (JP) | 2016-10-18 | — | — | US | disclosed |
| US-20160263074-A1 | METAL-SALEN COMPLEX COMPOUND, LOCAL ANESTHETIC AND ANTINEOPLASTIC DRUG | ISHIKAWA YOSHIHIRO (JP) | 2016-09-15 | — | — | US | disclosed |
| US-20140206635-A1 | METAL-SALEN COMPLEX COMPOUND, LOCAL ANESTHETIC AND ANTINEOPLASTIC DRUG | IHI CORPORATION (JP) | 2014-07-24 | — | — | US | disclosed |
| US-20140046021-A1 | SELF-MAGNETIC METAL-SALEN COMPLEX COMPOUND | IHI CORPORATION (JP) | 2014-02-13 | — | — | US | disclosed |
| US-20140011032-A1 | METAL-SALEN COMPLEX COMPOUND AND METHOD FOR PRODUCING THE SAME | IHI CORPORATION (JP) | 2014-01-09 | — | — | US | disclosed |
| US-20130131367-A1 | ANTI-BRAIN-TUMOR DRUG | IHI CORPORATION (JP) | 2013-05-23 | — | — | US | disclosed |
| US-20130090539-A1 | FLUOROCHROME MATERIAL AND METHOD FOR USING THE SAME | IHI CORPORATION (JP) | 2013-04-11 | — | — | US | disclosed |
| EP-2557155-A1 | METAL SALEN COMPLEX DERIVATIVE AND PROCESS FOR PRODUCTION THEREOF | IHI Corporation (JP) | 2013-02-13 | — | — | EP | disclosed |
| US-20130029399-A1 | METAL SALEN COMPLEX DERIVATIVE AND PROCESS FOR PRODUCTION THEREOF | YOSHIHIRO ISHIKAWA (JP) | 2013-01-31 | — | — | US | disclosed |
| US-20120029167-A1 | AUTO MAGNETIC METAL SALEN COMPLEX COMPOUND | YOSHIHIRO ISHIKAWA (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20090169484-A1 | IRON-SALEN COMPLEX | IHI CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090169484-A1 | IRON-SALEN COMPLEX | IHI CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130131367-A1 | ANTI-BRAIN-TUMOR DRUG | SLC30A5, SLC40A1, AIFM2 | TSHR 404/4885ALDH1A1 2909/4885KDM4E 1160/4885 |
| US-20120029167-A1 | AUTO MAGNETIC METAL SALEN COMPLEX COMPOUND | SDHB, SDHA, SLC40A1 | TSHR 3537/4885ALDH1A1 2998/4885KDM4E 2197/4885 |
| US-20140206635-A1 | METAL-SALEN COMPLEX COMPOUND, LOCAL ANESTHETIC AND ANTINEOPLASTIC DRUG | NCLN, KCNN2, NCSTN | TSHR 3871/4885ALDH1A1 1531/4885KDM4E 2587/4885 |
| US-10034851-B2 | Metal-salen complex compound, local anesthetic and antineoplastic drug | NCLN, KCNN2, NCSTN | TSHR 3871/4885ALDH1A1 1531/4885KDM4E 2587/4885 |
| US-10034941-B2 | Iron-salen complex | SLC40A1, SDHB, TFRC | TSHR 1446/4885ALDH1A1 904/4885KDM4E 2864/4885 |
| US-20140046021-A1 | SELF-MAGNETIC METAL-SALEN COMPLEX COMPOUND | SSBP1, KCNN1, IMMT | TSHR 4241/4885ALDH1A1 2799/4885KDM4E 3391/4885 |
| US-20130029399-A1 | METAL SALEN COMPLEX DERIVATIVE AND PROCESS FOR PRODUCTION THEREOF | NCLN, SPEN, SSBP1 | TSHR 3782/4885ALDH1A1 2808/4885KDM4E 3433/4885 |
| US-20130090539-A1 | FLUOROCHROME MATERIAL AND METHOD FOR USING THE SAME | MB, FECH, TFRC | TSHR 1854/4885ALDH1A1 1453/4885KDM4E 3497/4885 |
| US-20170240581-A1 | ANTI-CANCER AGENT AND CANCER CELL KILLING METHOD | BOD1L1, NUMA1, BUB1 | TSHR 4746/4885ALDH1A1 3810/4885KDM4E 3993/4885 |
| US-20090169484-A1 | IRON-SALEN COMPLEX | SLC40A1, SDHB, TFRC | TSHR 1446/4885ALDH1A1 904/4885KDM4E 2864/4885 |
| US-20160263074-A1 | METAL-SALEN COMPLEX COMPOUND, LOCAL ANESTHETIC AND ANTINEOPLASTIC DRUG | NCLN, KCNN2, NCSTN | TSHR 3871/4885ALDH1A1 1531/4885KDM4E 2587/4885 |
| US-10030039-B2 | Anti-cancer agent and cancer cell killing method | BOD1L1, NUMA1, BUB1 | TSHR 4746/4885ALDH1A1 3810/4885KDM4E 3993/4885 |
| US-20140011032-A1 | METAL-SALEN COMPLEX COMPOUND AND METHOD FOR PRODUCING THE SAME | SNRNP200, MB, SDHB | TSHR 568/4885ALDH1A1 3591/4885KDM4E 2428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.